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Background: Insulin resistance (IR) is the key feature of the metabolic syndrome (MetS) and in prospective studies predicts atherothrombotic 
events. Its association with directly visualised coronary atherosclerosis is unclear. We hypothesised that IR is associated with both angiographically 
determined coronary artery disease (CAD) and with the MetS.
Methods: We enrolled 986 consecutive patients undergoing coronary angiography for the evaluation of suspected or established stable CAD; 
significant CAD was diagnosed in the presence of ignificant coronary stenoses with lumen narrowing ≥50%. IR was determined by the HOMA index; 
the MetS was defined according to ATPIII criteria.
Results: HOMA IR scores were significantly higher in MetS patients than in subjects without the MetS (6.4 ± 2.1 vs. 2.2 ± 2.0; p <0.001). In 
contrast HOMA-IR did not differ significantly between patients with significant CAD and those who did not have significant CAD (3.9 ± 14 vs. 3.2 ± 
4; p = 0.490). When both, the presence of MetS and of significant CAD were considered, HOMA-IR was significantly higher in patients with the MetS 
both among those who had significant CAD (7.2 ± 28 vs. 2.3 ± 2.1; p <0.001) and among those who did not have significant CAD (5.3 ± 5.7 vs. 2.1 
± 1.4; p <0.001) whereas it did not differ significantly between patients with significant CAD and subjects without significant CAD in patients with 
the MetS (7.2 ± 28 vs. 5.3 ± 5.7; p = 0.679) nor in those without MetS (2.1 ± 1.4 vs. 2.3 ± 2.1; p = 0.411). Similar results were obtained with the 
IDF definition of the metabolic syndrome.
Conclusion: IR is significantly associated with the MetS but not with angiographically determined coronary atherosclerosis.
